EMEdward Marschall

Edward Marschall

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Edward Marschall has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Max J. Cryle

    Department of Biochemistry and Molecular Biology The Monash Biomedicine Discovery Institute Monash University Clayton Victoria Australia

    6 shared publications
  • Julien Tailhades

    Department of Biochemistry and Molecular Biology The Monash Biomedicine Discovery Institute Monash University Clayton Victoria Australia

    4 shared publications
  • Alasdair McKay

    Department of Chemistry Monash University Clayton VIC 3800 Australia

    2 shared publications
  • David L. Steer

    Monash Proteomics and Metabolomics Facility Monash University Clayton VIC 3800 Australia

    2 shared publications
  • David R. Nelson

    Department of Microbiology, Immunology and Biochemistry University of Tennessee Memphis TN 38163 USA

    2 shared publications
  • Leo Padva

    Institute of Pharmaceutical Biology University of Bonn 53115 Bonn Germany

    2 shared publications

Latest Publications

  • Open Access

    Nitrogen deletion in HDAC-targeting anticancer drug biosynthesis

    by Xinyun Jian, Jinlian Zhao, Edward M. Marschall, Kai-Chen Wu, Chuan Huang, Munro Passmore, Douglas M. Roberts, David P. Fairlie, Max J. Cryle, Lona M. Alkhalaf, et al.

    Summary: Small molecules play indispensable roles in living systems as hormones, membrane bilayer constituents, enzyme cofactors, metal chelators, and defensive chemicals. The exceptional structural diversity of such molecules underpins their wide-ranging biological functions. Precise functional group insertion into various molecular scaffold classes is a hallmark of small molecule biosynthesis and is frequently important for biological activity. Functional group deletion is also important, but mechanisms are less well understood. Here, we report deletion of a cysteine-derived nitrogen atom during assembly of the conserved pharmacophore in the anticancer drug romidepsin, and related depsipeptide HDAC inhibitors. A shunt metabolite hydroxylated at the cysteine-α-carbon-derived position is a thousand-fold less active, indicating nitrogen deletion is important for potent HDAC inhibition. In vitro reconstitution and dissection of the complete nonribosomal peptide synthetase-polyketide synthase-mediated pathway for pharmacophore assembly reveal that cryptic S -octanoylation is catalysed by an atypical heterocyclisation domain, while multifunctional dehydratase and ketoreductase domains and trans -acting phosphotransferase and flavin-dependent oxidoreductase enzymes catalyse successive transformations in nitrogen deletion. Our findings significantly advance the understanding of heteroatom deletion mechanisms in small molecule biosynthesis and highlight the key role this can play in enhancing bioactivity. One-pot biocatalytic synthesis of the pharmacophore provides foundations for chemoenzymatic approaches to next-generation HDAC inhibitors.

  • Open Access

    Synthetic ramoplanin analogues are accessible by effective incorporation of arylglycines in solid-phase peptide synthesis

    by Edward Marschall, Rachel W. Cass, Komal M. Prasad, James D. Swarbrick, Alasdair I. McKay, Jennifer A. E. Payne, Max J. Cryle, Julien Tailhades

    Optimized solid-phase peptide synthesis (SPPS) conditions allow the incorporation of multiple arylglycine residues which is offering a new perspective on the peptide antibiotic ramoplanin.


  • Open Access

    Cytochrome P450BltEnables Versatile Peptide Cyclisation to Generate Histidine‐ and Tyrosine‐Containing Crosslinked Tripeptide Building Blocks

    by Yongwei Zhao, Edward Marschall, Maxine Treisman, Alasdair McKay, Leo Padva, Max Crüsemann, David R. Nelson, David L. Steer, Ralf B. Schittenhelm, Julien Tailhades, et al.

    We report our investigation of the utility of peptide crosslinking cytochrome P450 enzymes from biarylitide biosynthesis to generate a range of cyclic tripeptides from simple synthons. The crosslinked tripeptides produced by this P450 include both tyrosine‐histidine (A−N−B) and tyrosine‐tryptophan (A−O−B) crosslinked tripeptides, the latter a rare example of a phenolic crosslink to an indole moiety. Tripeptides are easily isolated following proteolytic removal of the leader peptide and can incorporate a wide range of amino acids in the residue inside the crosslinked tripeptide. Given the utility of peptide crosslinks in important natural products and the synthetic challenge that these can represent, P450 enzymes have the potential to play roles as important tools in the generation of high‐value cyclic tripeptides for incorporation in synthesis, which can be yet further diversified using selective chemical techniques through specific handles contained within these tripeptides.


  • Open Access

    Cytochrome P450BltEnables Versatile Peptide Cyclisation to Generate Histidine‐ and Tyrosine‐Containing Crosslinked Tripeptide Building Blocks

    by Yongwei Zhao, Edward Marschall, Maxine Treisman, Alasdair McKay, Leo Padva, Max Crüsemann, David R. Nelson, David L. Steer, Ralf B. Schittenhelm, Julien Tailhades, et al.

    We report our investigation of the utility of peptide crosslinking cytochrome P450 enzymes from biarylitide biosynthesis to generate a range of cyclic tripeptides from simple synthons. The crosslinked tripeptides produced by this P450 include both tyrosine‐histidine (A−N−B) and tyrosine‐tryptophan (A−O−B) crosslinked tripeptides, the latter a rare example of a phenolic crosslink to an indole moiety. Tripeptides are easily isolated following proteolytic removal of the leader peptide and can incorporate a wide range of amino acids in the residue inside the crosslinked tripeptide. Given the utility of peptide crosslinks in important natural products and the synthetic challenge that these can represent, P450 enzymes have the potential to play roles as important tools in the generation of high‐value cyclic tripeptides for incorporation in synthesis, which can be yet further diversified using selective chemical techniques through specific handles contained within these tripeptides.


  • Characterization of the Core Ribosomal Binding Region for the Oxazolidone Family of Antibiotics Using Cryo-EM

    by Alexander Wright, Kieran Deane-Alder, Edward Marschall, Rebecca Bamert, Hari Venugopal, Trevor Lithgow, David W. Lupton, Matthew J. Belousoff

    Linezolid and tedizolid are oxazolidinones with established clinical utility for the treatment of Gram-positive pathogens. Over time it has become apparent that even modest structural changes to the core phenyl oxazolidinone leads to drastic changes in biological activity. Consequently, the structure–activity relationship around the core oxazolidinone is constantly evolving, often reflected with new structural motifs present in nascent oxazolidinones. Herein we describe the use of cryo-electron microscopy to examine the differences in binding of several functionally different oxazolidinones in the hopes of enhanced understanding of their SAR. Tedizolid, radezolid, T145, and contezolid have been examined within the peptidyl transferase center (PTC) of the 50S ribosomal subunit from methicillin resistant Staphylococcus aureus. The ribosome–antibiotic complexes were resolved to a resolution of around 3 Å enabling unambiguous assignment of how each antibiotic interacts with the PTC.


  • Open Access

    Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics

    by Edward Marschall, Max J. Cryle, Julien Tailhades


  • Open Access

    A proof-reading mechanism for non-proteinogenic amino acid incorporation into glycopeptide antibiotics

    by Milda Kaniusaite, Julien Tailhades, Edward A. Marschall, Robert J. A. Goode, Ralf B. Schittenhelm, Max J. Cryle

    Non-ribosomal peptide biosynthesis produces highly diverse natural products through a complex cascade of enzymatic reactions that together function with high selectivity to produce bioactive peptides. The modification of non-ribosomal peptide synthetase (NRPS)-bound amino acids can introduce significant structural diversity into these peptides and has exciting potential for biosynthetic redesign. However, the control mechanisms ensuring selective modification of specific residues during NRPS biosynthesis have previously been unclear. Here, we have characterised the incorporation of the non-proteinogenic amino acid 3-chloro-β-hydroxytyrosine during glycopeptide antibiotic (GPA) biosynthesis. Our results demonstrate that the modification of this residue by trans-acting enzymes is controlled by the selectivity of the upstream condensation domain responsible for peptide synthesis. A proofreading thioesterase works together with this process to ensure that effective peptide biosynthesis proceeds even when the selectivity of key amino acid activation domains within the NRPS is low. Furthermore, the exchange of condensation domains with altered amino acid specificities allows the modification of such residues within NRPS biosynthesis to be controlled, which will doubtless prove important for reengineering of these assembly lines. Taken together, our results indicate the importance of the complex interplay of NRPS domains and trans-acting enzymes to ensure effective GPA biosynthesis, and in doing so reveals a process that is mechanistically comparable to the hydrolytic proofreading function of tRNA synthetases in ribosomal protein synthesis.